Yan Tang

机构：Shanghai East Hospital · ORCID：0000-0002-5513-6453

发表论文 175 篇 · 总被引 4449 次 · h-index 32

代表论文

• Clinical advances of mRNA vaccines for cancer immunotherapy (2025 · Med · 被引 105)
• XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial (2024 · Signal Transduction and Targeted Therapy · 被引 35)
• Mechanisms of Heavy Metal Cadmium (Cd)-Induced Malignancy (2024 · Biological Trace Element Research · 被引 28)
• In Silico-Guided Discovery of Polysaccharide Derivatives as Adjuvants in Nanoparticle Vaccines for Cancer Immunotherapy (2025 · ACS Nano · 被引 20)
• Interpretable mortality prediction model for ICU patients with pneumonia: using shapley additive explanation method (2024 · BMC Pulmonary Medicine · 被引 20)
• Genome-wide survey of KT/HAK/KUP genes in the genus Citrullus and analysis of their involvement in K+-deficiency and drought stress responses in between C. lanatus and C. amarus (2024 · BMC Genomics · 被引 7)